Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

NCT: NCT02530073 · RECRUITING

NCT IDNCT02530073
StatusRECRUITING
Start Date2015-09
Completion2030-08
SponsorConnecticut Children's Medical Center (OTHER)
First posted
Last updated

Brief Summary

The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.

Frequently Asked Questions

What is Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH?

Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH is a clinical trial registered under NCT02530073. Current status: RECRUITING.

What is the status of NCT02530073?

The current status of NCT02530073 (Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH) is: RECRUITING.

When did Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH start?

Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH started on 2015-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑